IgA nephropathy: open trials in Sweden

• NCT06963827

  A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

  Trial Treatment · Phase 3 · Takeda

  Region Oestergoetland, Linkoping

  Registry updated 2026-11-04

• NCT04557462

  A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Karolinska University Hospital, Huddinge

  Registry updated 2026-10-05

• NCT05003986

  Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

  Trial Treatment · Phase 2 · Travere Therapeutics, Inc.

  Queen Silvia Childrens Hospital - Sahlgrenska University Hospital - Vastra Gotalandsregionen, Gothenburg · Karolinska Universitetsjukhuset Huddinge, Huddinge

  Registry updated 2026-05-12

All IgA nephropathy trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error